Avhopp i Astrazenecas topp

I drygt tjugo år har han verkat i läkemedelsjättens högsta ledning, bland annat som koncernchef. I samband med årsstämman slutar han som bolagets vice ordförande.

Hoppfullt för hiv-läkemedel

En nyligen avslutad studie av en antikroppsterapi visar på positiva resultat.

MVAs vice vd på plats

Nu har Charlotte Ahlgren, ny vice vd för Medicon Valley Alliance tillträtt sin post.

Hallå där Bengt Lövdén

som har utsetts till tillförordnad VD för forskningsparken Medeon Science Park i Malmö, en post som han tillträder omedelbart.

Ny hövding till Roche

Roche har utsett en efterträdare till nypensionerade Curt Collin på posten som chef för External Affairs.

Hon ska göra högskolan mer jämställd

Män dominerar på högre poster och förändringstakten är oacceptabelt långsam. Regeringen har tillsatt en delegation som ska förbättra jämställdheten i högskolan. Den avgående rektorn för Luleå Tekniska universitet ska leda arbetet.

Gyros får ny vd

Tillförordnade vd Lars Eric Utterman övergår till att bli styrelseledamot när en ordinarie verkställande direktör nu har utsetts.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Metabolic pro heads prefect post

The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.

Laboratorieassistent till Olink

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

New head of Vinnova

While waiting for a new gerenal-director, Vinnova has got a substitute general-director.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.